ClinicalTrials.gg
Status unknownNCT03892083Updated Aug 8, 2023

Effect of tDCS on Postural Control of Children With DCD

An interventional study of Transcranial direct current stimulation (tDCS) in Developmental Coordination Disorder, sponsored by University of Sao Paulo General Hospital. Status unknown at 1 site in Brazil. Open to participants aged 7 Years to 11 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-08-08.

Sponsored by University of Sao Paulo General Hospital · Not applicable, Interventional, and Basic science

The sponsor has not verified this record recently (last verified Mar 2023), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
7 Years to 11 Years
Sex
All
01

Study summary

This study investigates the effects of Transcranial Direct Current Stimulation (tDCS) on postural control of children with Developmental Coordination Disorder (DCD). All participants will receive four conditions of stimulation, in a crossover protocol: cerebellar anodic, cerebellar cathodic, primary motor cortex anodic (M1) or sham tDCS.

Read the detailed description

Developmental Coordination Disorder (DCD) is a highly frequent neurodevelopmental disorder with negative impacts on children's motor repertoire, quality of life and general health. One of the main problems faced is the balance deficit, which although well characterized in this population, little is known about the etiological core of this impairment. The cerebellum appears to be a functionally impaired structure in DCD, but frontal motor areas are also involved. Transcranial Direct Current Stimulation (tDCS) is a noninvasive way of inducing local-specific polarity-dependent synaptic modulation. Cerebellar tDCS (CE-tDCS) is even more recent, with still unclear results on its effects on postural balance, with only one study in children, which requires us to better understand the type of stimulation necessary to induce balance improvement in children with DCD.

Thus, the investigators aimed to verify the effects of anodal tDCS over primary motor cortex (M1-atDCS) and CE-tDCS (anodic, cathodic and sham) on the balance of children with DCD, compared to children without DCD.

METHODS: Fifteen children with DCD (total MABC-2 and balance \<15%, with DCDQ positive / TL positive) and 15 children without DCD (MABC-2 total and balance ≥50% and DCDQ negative) will be assessed by platform stabilometry (PS) before and after receiving M1, cerebellar anodic, cerebellar cathodic, primary motor cortex anodic (M1) or sham tDCS (crossover). They will be evaluated under conditions without proprioceptive manipulation (direct on PS) with open and closed eyes, and with proprioceptive manipulation (on foam surface) with open and closed eyes.

02

Conditions studied

  • Developmental Coordination Disorder

Browse trials for

Keywords

  • Developmental coordination disorder
  • Postural balance
  • Transcranial Direct Current Stimulation
  • Children
  • Child Development
03

In context

Motor Skills Disorders

98 studies on the registry are indexed under Motor Skills Disorders; 26 are open to participants now.

This study's enrollment of 40 is close to the median of 40 across 71 interventional studies indexed under Motor Skills Disorders.

Browse Motor Skills Disorders studies →

Lead sponsor

University of Sao Paulo General Hospital is the lead sponsor of 609 studies on the registry; 98 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • children of both sex, aged between seven years 0 months and 10 years and 11 months;
  • Assent of the child by the Term of Assent and acceptance of parents and / or guardians to participate in the study by signing the Free and Informed Consent Form;
  • Children with DCD indicative according to DSM-5 presenting Percentile \<15 in the MABC-2 Motor Evaluation Battery and in the balance domain; and the score indicated for each age by the Developmental Coordination Disorder Questionnaire DCDQ-Brazil (TDC Group).
  • Children without DCD presenting Percentile ≥ 50 in the total score and in the MABC-2 Motor Assessment Battery Balance domain, without indicative by DCDQ (Control Group - GC).
  • Absence of intellectual disability considering performance above the 25th percentile on the RAVEN Color Progressive Matrix scale
  • Absence of visual or auditory deficiencies; cardiopathies; rheumatic or orthopedic dysfunctions; neurological or psychiatric problems (except ADHD and language disorder because they are the most comorbid disorders with DCD).

Exclusion criteria

Exclusion Criteria:

  • Signs of excessive discomfort during or after any procedures or sessions involved in the research.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
40 participants (actual)

Study arms

  • Active comparator
    Anodal tDCS (M1)

    tDCS applied over primary motor cortex. Dose: 1mA, 20 minutes

    Device: Transcranial direct current stimulation (tDCS)

  • Experimental
    Anodal Cerebellar tDCS

    tDCS applied over the cerebellum. Dose: 1mA, 20 minutes

    Device: Transcranial direct current stimulation (tDCS)

  • Experimental
    Cathodal Cerebellar tDCS

    tDCS applied over the cerebellum. Dose: 1mA, 20 minutes

    Device: Transcranial direct current stimulation (tDCS)

  • Sham comparator
    Sham tDCS

    tDCS applied over the cerebellum Dose: 1mA, 20 minutes (30s ON)

    Device: Transcranial direct current stimulation (tDCS)

Interventions

  • DeviceTranscranial direct current stimulation (tDCS)

    Transcranial direct current stimulation is a noninvasive technique of neuronal modulation that has been used in different neurological conditions, including children with cerebral palsy.

06

What researchers measure

Primary outcomes

  1. Change from COP - AP axis

    Postural instability will be evaluated using a force plate to record center of pressure displacement (COP) in antero-posterior (AP) axis in centimeters

    Time frame: Baseline and Post-tDCS (immediately after tDCS)

  2. Change from COP - ML axis

    Postural instability will be evaluated using a force plate to record center of pressure displacement (COP) in Mediolateral (ML) axis in centimeters

    Time frame: Baseline and Post-tDCS (immediately after tDCS)

  3. Change from COP - area

    Postural instability will be evaluated using a force plate to record center of pressure displacement (COP) area (cm²)

    Time frame: Baseline and Post-tDCS (immediately after tDCS)

Other outcomes

  1. Adverse effects

    Adverse effects will be evaluated using structured questionnaire. Active collection uses a questionnaire with records of the duration (minutes or hours) and intensity (Numerical Rating Scale 0-10) of adverse symptoms reported by the patient. Complaints: Headache Scalp pain Tingling Itching Redness Burning sensations Sleepiness Trouble concentrating Nausea Mood change

    Time frame: Immediately after tDCS

07

Study locations

1 site
  • Department of Physical Therapy, Communication Sciences and Disorders, and Occupational Therapy, Faculty of Medicine, University of São Paulo
    São Paulo, 01246-903, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03892083
Responsible party
Sponsor
First posted
Mar 27, 2019
Start date
Feb 1, 2019
Primary completion
Apr 27, 2022
Completion
Dec 20, 2023 (estimated)
Last update
Aug 8, 2023

Study contacts

Renata H Hasue, pHD
principal investigator · University of Sao Paulo

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion